What does Disney’s acquisition of 21st Century Fox have to do with the repeal of net neutrality?
Andrew McCollum, CEO of streaming service Philo TV, says that a deregulated internet environment will incentivize major distribution companies to get into the programming space.
“There no longer will be strong rules preventing them from leveraging their infrastructures to gain an advantage in the marketplace over potential competitors,” he said in an interview on Cheddar.
Expectations that the FCC would vote to roll back protections sparked protests from internet users and enterprises alike. When the decision came down, Netflix tweeted its disappointment, saying that the agency’s “misguided order” would be the beginning of a long legal battle.
McCollum, who spoke before the FCC voted, pointed out that the end of net neutrality gives consumers the short end of the stick.
“You just have to imagine a world where, if you’re using Comcast and you’re trying to access [its] NBC content, it works really well. [But] if you’re trying to watch Netflix, suddenly it’s really slow.”
For full interview [click here](https://cheddar.com/videos/the-fight-for-a-free-internet).
Joe Spector, founder of Dutch and Hims & Hers co-founder, joins us to discuss how telehealth is transforming pet care—and what’s next for modern vet medicine.
Exclusive: Behr’s Andy Lopez reveals how ChatHUE, a bold collaboration with Google, is using AI to transform how we explore, choose, and connect with color.
Brian Vendig, President & CIO of MJP Wealth Advisors, joins to break down Q2 bank earnings and what they signal for markets, investors, and the economy ahead.
Are Gen Z and Millennials done with alcohol? Bacardi's Tony Latham breaks down trends, new preferences, and insights from the 2025 Cocktail Trends Report.
Comscore’s Paul Dergarabedian breaks down the battle of summer blockbusters, from Superman to Jurassic World and Fantastic Four and what it means for studios.
VENU CEO JW Roth breaks ground on a 20,000-seat, state-of-the-art amphitheater in Texas—part of a $300M public-private expansion to redefine live music.
Despite healthcare spending cuts, medtech stocks like Edwards Life Sciences, Stryker, and Boston Scientific are rising, especially those serving older pati
